Eliška Macková

Comparison of Clinically Used and Experimental Iron Chelators for Protection against Oxidative Stress-Induced Cellular Injury

Petra Bendová, Eliška Macková, Pavlína Hašková et al. · Chemical Research in Toxicology · 2010 · 71 citations

Inflammation, Iron Imbalance, Biochemistry +13

Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells

Anna Vávrová, Hana Jansová, Eliška Macková et al. · PLoS ONE · 2013 · 70 citations · Full text

Lipid Peroxidation, Pharmacotherapy, Cardiovascular Toxicity +18

Synthesis and Initial <i>in Vitro</i> Evaluations of Novel Antioxidant Aroylhydrazone Iron Chelators with Increased Stability against Plasma Hydrolysis

Kateřina Hrušková, Petra Kovařı́ková, Petra Bendová et al. · Chemical Research in Toxicology · 2011 · 54 citations

Pharmaceutical Chemistry, Oxysterol, Biochemistry +13

Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity

Pavlína Hašková, Petra Kovařı́ková, Lucie Koubková et al. · Free Radical Biology and Medicine · 2010 · 47 citations

Biochemistry, Iron Chelation, Medicine +9

Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: Novel iron chelators with selective antiproliferative action

Eliška Macková, Kateřina Hrušková, Petra Bendová et al. · Chemico-Biological Interactions · 2012 · 45 citations

Novel Iron Chelators, Biochemistry, Natural Sciences +7